Coagulation cascade — tissue-factor initiation, FXI/FIX amplification, prothrombinase, fibrin formation and cross-linking, with the plasma anticoagulant brakes

The coagulation cascade converts a local vascular injury into an insoluble, cross-linked fibrin clot through a chain of limited proteolytic activations of circulating zymogens and their non-enzymatic protein cofactors. Initiation is extrinsic: tissue factor (F3), an integral membrane protein exposed at the injury site, binds factor VII/VIIa (F7) and the resulting extrinsic tenase complex cleaves both factor X (F10) and factor IX (F9). The small amount of thrombin this generates feeds back to activate the cofactors factor V (F5) and factor VIII (F8) and the zymogen factor XI (F11), switching the system into its amplification mode: factor XIa activates factor IX, and factor IXa together with factor VIIIa forms the intrinsic tenase that sustains factor Xa production. Factor VIII circulates bound to von Willebrand factor (VWF), which carries it and protects it from clearance until thrombin releases it. The pathways converge on the prothrombinase complex, factor Xa with its cofactor factor Va on a procoagulant phospholipid surface, which raises the rate of prothrombin (F2) activation by several orders of magnitude. Thrombin then cleaves fibrinopeptides from fibrinogen (FGA, FGB, FGG); the fibrin monomers polymerise into a branched network by their own end-to-middle and lateral associations, and thrombin-activated factor XIII (the catalytic A subunit F13A1 with its carrier B subunit F13B) covalently cross-links the gamma chains, stabilising the clot and making it resistant to lysis. The same proteases are held in check by plasma anticoagulants: antithrombin (SERPINC1) traps thrombin, factor Xa and factor IXa; tissue factor pathway inhibitor (TFPI) shuts down the extrinsic tenase and factor Xa; the protein C pathway, in which thrombin bound to endothelial thrombomodulin (THBD) activates protein C (PROC) and activated protein C with its cofactor protein S (PROS1) destroys factors Va and VIIIa, removes the cofactors the cascade depends on; and protein Z-dependent protease inhibitor (SERPINA10) with protein Z (PROZ) inactivates factor Xa at the membrane surface. Most of the proteases and protein C, S and Z are vitamin K-dependent, their Gla domains anchoring them to the anionic phospholipid surface.

MODULE:coagulation_cascadeDRAFTCONCRETEBiological Processmodules/coagulation_cascade.yaml
blood coagulation, fibrin clot formationGO:0072378
PW:0000474
coagulation cascade pathway
The module boundary, its members and its topology follow the RGD interactive diagram for this Pathway Ontology term. The diagram draws F3 associated with F7a, F10 associated with the TF/F7a complex, the TF/F7a complex activating F10a and F9a, F12a activating F11a, F11a activating F9a, F9a activating F8a, the tenase complex activating F10a, the prothrombinase complex activating F2a, F2a acting on fibrinogen and on fibrin, pF13 activating pF13a, pF13a driving fibrin polymerization and cross-linking, F8 associated with Vwf, and the anticoagulant arms Tfpi (on the extrinsic tenase complex), Serpinc1 (on F2a, F9a and F10a), activated protein C (on F5a and F8a), and Proz associated with Serpina10 (on F10a). Derived through projects/RGD_PATHWAY_ONTOLOGY (pathways/PW_0000474.yaml).
PW:0000480
protein C anticoagulant pathway
The module's protein C part also covers this RGD pathway, which PW defines as activated protein C, aided by protein S, inactivating F8a and F5a. Five of its six RGD human genes are members here (F2, F5, PROC, PROS1, THBD). The endothelial protein C receptor (PROCR), which presents protein C to the thrombin-thrombomodulin complex, is not modelled.
GO:0072378
blood coagulation, fibrin clot formation
The module is grounded in GO blood coagulation, fibrin clot formation, which is also the PW->GO candidate mapping recorded for PW:0000474 in the project's seed table. Its three GO children — blood coagulation, extrinsic pathway (GO:0007598), intrinsic pathway (GO:0007597) and common pathway (GO:0072377) — correspond to the module's initiation, amplification and prothrombinase parts, so the parent is the most specific term covering the whole module.
GO:0030195
negative regulation of blood coagulation
The regulatory part of the module (antithrombin, TFPI, the protein C pathway and protein Z/ZPI) is grounded in negative regulation of blood coagulation, the process term carried experimentally by F2 (IDA), PROC (IDA), THBD (IDA) and TFPI (IDA).
gomodel:666b894f00000232
Thrombin-Thrombomodulin pair activating Protein C activation (Human)
A curator-built human GO-CAM (cached under gocams/666b894f00000232/) models the protein C arm of this module with matching molecular functions: THBD signaling receptor activity (GO:0038023) at the plasma membrane regulating F2 serine-type endopeptidase activity (GO:0004252), which in turn is causally upstream of PROC serine-type endopeptidase activity (GO:0004252), all part of negative regulation of blood coagulation (GO:0030195) in the extracellular region. Three sibling models (gomodel:665912ed00003542, gomodel:665912ed00003594, gomodel:666b894f00000010) carry the same three activities with different upstream thrombomodulin partners. No cached production GO-CAM covers the procoagulant steps of this module.
PMID:3422166
The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
States the extrinsic initiation step and the dual target of TFPI, which together set the module's first part and its first anticoagulant brake.
Blood coagulation is initiated when plasma factor VII(a) binds to its essential cofactor tissue factor (TF) and proteolytically activates factors X and IX.
PMID:8083241
A model for the tissue factor pathway to thrombin. I. An empirical study.
Reconstitution of the whole tissue-factor pathway at plasma concentrations: the lag before explosive thrombin generation is the interval of cofactor (FV, FVIII) activation, establishing the feedback part of this module as rate-controlling.
The lag was a function of tissue factor/factor VIIa concentration and represented primarily the interval of factor V and factor VIII activation.
PMID:16102057
Fibrinogen and fibrin structure and functions.
Defines the output steps: thrombin cleaves fibrinopeptide A to start polymerisation, the fibrils themselves build the network, and factor XIII(a) cross-links the gamma chains.
Fibrin is formed after thrombin cleavage of fibrinopeptide A (FPA) from fibrinogen Aalpha-chains, thus initiating fibrin polymerization.
PMID:21742792
Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.
Places factor XIII as the last step of the cascade and names its substrate state (insoluble fibrin), supporting the clot-stabilisation part.
it is a protransglutaminase, which becomes activated in the last stage of coagulation

Derived from the RGD Pathway Ontology diagram PW:0000474 through the RGD_PATHWAY_ONTOLOGY project. The diagram supplied the boundary, members and topology; GO terms were then chosen against each protein's experimental GOA annotations in QuickGO (F7 GO:0004252 TAS and contributes_to IDA; F9 GO:0004252 EXP; F10 GO:0004252 IDA; F11 GO:0004252 TAS with GO:0031638 zymogen activation IDA; F2 GO:0004252 IDA with GO:0030194 and GO:0030195 IDA; PROC GO:0004252 IMP/TAS; F13A1 GO:0003810 IDA with GO:0018149 IDA; FGA, FGB and FGG GO:0005198 IDA with GO:0072378 IDA; VWF GO:0140597 from its gene review; SERPINC1 and SERPINA10 GO:0004867; THBD GO:0038023 IDA). Four cofactor roles have no supporting molecular function in GOA and are asserted here as curator judgment, flagged rather than hidden. Tissue factor (F3), factor Va (F5) and factor VIIIa (F8) are given endopeptidase activator activity (GO:0061133): each is a non-enzymatic protein cofactor whose only job is to raise the catalytic efficiency of a partner serine protease by orders of magnitude (PMID:7350159, PMID:6782101), and F3 already carries contributes_to serine-type endopeptidase activity (GO:0004252, IDA PMID:24998411) for the same complex. Protein S (PROS1) is given peptidase activator activity (GO:0016504) because it accelerates APC-catalysed factor Va inactivation (PMID:6892911); its only GOA molecular function is protein binding, which this project does not use. Protein Z (PROZ) is left without a molecular function: it is the membrane cofactor in the factor Xa-PZ-ZPI complex (PMID:9689066) and no GO term describes that role, while its IBA GO:0004252 is implausible for a protein with a degenerate catalytic triad; this is recorded as a doubt rather than corrected here. Factor XIII B subunit (F13B) is likewise functionless, carrying only the fibrin-clot-formation process it has by IDA, because its role is to carry and stabilise the A subunit. Thrombomodulin keeps the GO:0038023 signaling receptor activity for consistency with its IDA annotation and the four cached protein C GO-CAMs; the annoton's role description states that the term does not describe its cofactor role. Fibrinogen follows the substrate-versus-participant rule: it is thrombin's substrate, but the polymerisation and network formation are its own work, so FGA, FGB and FGG are modelled with structural molecule activity and the fibrin-clot-formation and protein-polymerization processes they carry by IDA, not with any protease term. Deliberately outside this module. Contact activation (F12, KLKB1, KNG1) belongs to modules/kallikrein_kinin_cascade.yaml; it is drawn on the RGD diagram and is retained here only as the upstream connection into FXI activation (F12a activating F11), which the revised model of coagulation shows is also, and in vivo mainly, performed by thrombin (PMID:1652157). Fibrinolysis (PLG, PLAT and partners) belongs to modules/fibrinolysis.yaml, which takes cross-linked fibrin from this module as its input. The vitamin K cycle (GGCX, VKORC1) is cofactor supply for the Gla domains of F2, F7, F9, F10, PROC, PROS1 and PROZ and is a separate module; platelet activation and the protease-activated receptors (F2R, F2RL1, F2RL2, F2RL3) are downstream signalling outputs, not steps of fibrin formation. SERPING1 (C1 inhibitor) is on the RGD gene list but its coagulation targets are FXIIa, FXIa and kallikrein — the contact system — so it is placed with modules/kallikrein_kinin_cascade.yaml; its action on FXIa partly overlaps this module and is noted there. APOH (beta-2-glycoprotein I) appears in RGD's wider gene list for this pathway but is an anionic-phospholipid-binding plasma protein best known as the antiphospholipid-antibody antigen, not a step in the cascade, and is excluded. Gene reviews exist only for VWF (and APOH); the remaining twenty members are unreviewed, which is a curation gap recorded in the project plan rather than a knowledge gap here.

8Nodes
7Parts
0Variant Sets
0Variants
24Annotons
12Connections

Derived QC

Recommended-field compliance

84.6% recommended fields populated
  • knowledge_gaps[0].provenance[0] · reference_section_type (0/1)
  • knowledge_gaps[1].provenance[0] · reference_section_type (0/1)

Module deep research

✗ none found

No MODULE:coagulation_cascade deep-research report alongside the module YAML.

Leaf nodes lacking representative members

✓ every leaf node grounds to a representative protein.

Template conformance

✓ every declared conforms_to bundle matches its template motif.

Function consistency and core coverage

15 gene-function check(s) reflected in core functions · 0 conflict(s) · 7 evidence or coverage gap(s) (22 comparison(s))

Retained noncore functions are reported separately; they do not require promotion to core functions. Support from representative genes does not establish conservation across the whole family. Missing reviews or identifiers leave a claim unverified.

AnnotonParticipantFunctionAssessment
f3_tissue_factor F3
UniProtKB:P13726
Gene
endopeptidase activator activity
GO:0061133
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked.
f7_extrinsic_tenase F7
UniProtKB:P08709
Gene
serine-type endopeptidase activity
GO:0004252
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
f11_fix_activation F11
UniProtKB:P03951
Gene
serine-type endopeptidase activity
GO:0004252
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
f9_intrinsic_tenase F9
UniProtKB:P00740
Gene
serine-type endopeptidase activity
GO:0004252
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
f8_tenase_cofactor F8
UniProtKB:P00451
Gene
endopeptidase activator activity
GO:0061133
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
vwf_fviii_carrier VWF
UniProtKB:P04275
Gene
protein carrier chaperone
GO:0140597
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
f2_cofactor_feedback F2
UniProtKB:P00734
Gene
serine-type endopeptidase activity
GO:0004252
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
f10_prothrombinase F10
UniProtKB:P00742
Gene
serine-type endopeptidase activity
GO:0004252
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
f5_prothrombinase_cofactor F5
UniProtKB:P12259
Gene
endopeptidase activator activity
GO:0061133
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
f2_fibrinogen_cleavage F2
UniProtKB:P00734
Gene
serine-type endopeptidase activity
GO:0004252
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
fga_fibrin_polymer FGA
UniProtKB:P02671
Gene
structural molecule activity
GO:0005198
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
fgb_fibrin_polymer FGB
UniProtKB:P02675
Gene
structural molecule activity
GO:0005198
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
fgg_fibrin_polymer FGG
UniProtKB:P02679
Gene
structural molecule activity
GO:0005198
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
f2_f13_activation F2
UniProtKB:P00734
Gene
serine-type endopeptidase activity
GO:0004252
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
f13a1_transglutaminase F13A1
UniProtKB:P00488
Gene
protein-glutamine gamma-glutamyltransferase activity
GO:0003810
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
serpinc1_antithrombin SERPINC1
UniProtKB:P01008
Gene
serine-type endopeptidase inhibitor activity
GO:0004867
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked.
tfpi_extrinsic_brake TFPI
UniProtKB:P10646
Gene
serine-type endopeptidase inhibitor activity
GO:0004867
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked.
thbd_thrombin_switch THBD
UniProtKB:P07204
Gene
signaling receptor activity
GO:0038023
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked.
f2_protein_c_activation F2
UniProtKB:P00734
Gene
serine-type endopeptidase activity
GO:0004252
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass).
proc_cofactor_inactivation PROC
UniProtKB:P04070
Gene
serine-type endopeptidase activity
GO:0004252
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked.
pros1_apc_cofactor PROS1
UniProtKB:P07225
Gene
peptidase activator activity
GO:0016504
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked.
serpina10_zpi SERPINA10
UniProtKB:Q9UK55
Gene
serine-type endopeptidase inhibitor activity
GO:0004867
Review Missing
No ai-review exists for this protein; its function and core-function coverage cannot yet be checked.

Feedback loops (advisory, prose-driven: a regulator counts as "feedback" when its own description says so)

✓ every negative regulator described as feedback has an upstream edge closing the loop.

  • coag_anticoagulant_regulation ⊣ coag_extrinsic_initiation [closed]
    coag_anticoagulant_regulation is regulated by coag_prothrombinase: feedback loop closed

Gene-review completeness (13/21 grounded genes reviewed)

4 complete review(s) · 1 with deep research · 8 missing review · 12 reviewed but lacking deep research

Gene Review Complete Deep research
F10 P00742 ✓ 55/58 ✗
F11 P03951 ✓ 37/38 ✗
F13A1 P00488 ✓ 47/48 ✗
F13B P05160 ✓ ✓ ✗
F2 P00734 ✓ ✓ ✗
F5 P12259 ✓ 50/55 ✗
F7 P08709 ✓ 56/76 ✗
F8 P00451 ✓ 51/53 ✗
F9 P00740 ✓ ✓ ✗
FGA P02671 ✓ 121/131 ✗
FGB P02675 ✓ 99/113 ✗
FGG P02679 ✓ 105/121 ✗
SERPINC1 P01008 ✗ — —
protein C P04070 ✗ — —
THBD P07204 ✗ — —
protein S P07225 ✗ — —
TFPI P10646 ✗ — —
F3 P13726 ✗ — —
PROZ P22891 ✗ — —
SERPINA10 Q9UK55 ✗ — —
VWF P04275 ✓ ✓ ✓

Details

Context
Homo sapiensNCBITaxon:9606
extracellular regionGO:0005576 plasma membraneGO:0005886
Blood coagulation cascadeBiological Processcoagulation_cascade
blood coagulation, fibrin clot formationGO:0072378
Context
Homo sapiensNCBITaxon:9606
extracellular regionGO:0005576 plasma membraneGO:0005886

Connections

The extrinsic tenase makes the first factor Xa, which with factor Va makes the first thrombin.
The extrinsic tenase also activates factor IX directly, entering the amplification loop without factor XIa (PMID:271951).
The intrinsic tenase sustains factor Xa production during the propagation phase, after TFPI has quenched the extrinsic tenase.
Prothrombinase supplies the thrombin that performs the feedback cleavages.
Thrombin activates factor XI and factor VIII, the entry point and the cofactor of the amplification loop. Contact activation by factor XIIa (modules/kallikrein_kinin_cascade.yaml) is the alternative, upstream route into factor XI activation.
Thrombin (with factor Xa) activates factor V, the cofactor of its own generating complex — the autocatalytic core of the cascade.
Thrombin is the protease that cleaves fibrinogen.
Fibrin polymer is the substrate of factor XIIIa, and assembly presents the aligned gamma-chain pairs it cross-links. Cross-linked fibrin is in turn the input of modules/fibrinolysis.yaml.
TFPI quenches the factor VIIa-tissue factor complex (PMID:3422166).
Activated protein C destroys factor VIIIa and antithrombin inhibits factor IXa, dismantling the intrinsic tenase.
Activated protein C cleaves factor Va, antithrombin and ZPI inhibit factor Xa, and antithrombin traps the thrombin produced.
Thrombin is also the activator of protein C once it is bound to thrombomodulin, so the cascade switches on its own brake.
Part 1: extrinsic initiation
Tissue factor-factor VIIa complex activation of factor X and factor IXReactioncoag_extrinsic_initiation

Tissue factor exposed at the site of injury binds factor VII/VIIa; the extrinsic tenase complex then cleaves factor X to factor Xa and factor IX to factor IXa, generating the first, small burst of thrombin.

blood coagulation, extrinsic pathwayGO:0007598

Annotons

Tissue factor cofactor activity in the extrinsic tenase
f3_tissue_factor
Participant: Gene Product: F3
Gene Product:

Function

endopeptidase activator activityGO:0061133
Targets: coagulation factor VII/VIIaUniProtKB:P08709

Processes

blood coagulation, extrinsic pathwayGO:0007598

Locations

plasma membraneGO:0005886

The only integral-membrane, non-proteolysed member of the cascade. Binding of tissue factor converts factor VIIa, which has very weak activity on its own, into a potent activator of factors X and IX; F3 carries contributes_to serine-type endopeptidase activity (GO:0004252, IDA) for this complex and also phospholipid binding (GO:0005543, IDA).

PMID:3422166
Tissue factor is the essential cofactor of factor VII(a) in the initiating step.
Blood coagulation is initiated when plasma factor VII(a) binds to its essential cofactor tissue factor (TF) and proteolytically activates factors X and IX.
Factor VIIa proteolytic activation of factors X and IX
f7_extrinsic_tenase
Participant: Gene Product: F7
Gene Product:

Function

serine-type endopeptidase activityGO:0004252
Substrates: coagulation factor XUniProtKB:P00742 coagulation factor IXUniProtKB:P00740

Processes

blood coagulation, extrinsic pathwayGO:0007598

Locations

plasma membraneGO:0005886

Vitamin K-dependent serine protease; essentially inactive until bound to tissue factor, after which it cleaves both factor X and factor IX. The dual substrate specificity is what lets the extrinsic route feed the intrinsic tenase as well as prothrombinase.

PMID:271951
The tissue factor-factor VII reaction product activates factor IX, and factor IXa then activates factor X — a route that bypasses factor XIa.
The reaction product of tissue factor and Factor VII functioned as a potent Factor IX activator in the assay system used. Activated Factor IX itself activated Factor X; thrombin failed to activate Factor IX.
PMID:3422166
Factor VII(a)-tissue factor proteolytically activates factors X and IX.
Blood coagulation is initiated when plasma factor VII(a) binds to its essential cofactor tissue factor (TF) and proteolytically activates factors X and IX.
Part 2: intrinsic amplification
Factor XIa-factor IXa-factor VIIIa amplification of factor X activationReactioncoag_intrinsic_amplification

Factor XIa activates factor IX; factor IXa with its thrombin-activated cofactor factor VIIIa forms the intrinsic tenase on the phospholipid surface and sustains factor Xa generation far beyond what the extrinsic route provides. Factor VIII reaches this step as a complex with von Willebrand factor.

blood coagulation, intrinsic pathwayGO:0007597

Annotons

Factor XIa activation of factor IX
f11_fix_activation
Participant: Gene Product: F11
Gene Product:

Function

serine-type endopeptidase activityGO:0004252
Substrates: coagulation factor IXUniProtKB:P00740

Processes

blood coagulation, intrinsic pathwayGO:0007597 zymogen activationGO:0031638

Locations

extracellular regionGO:0005576

Entry point of the amplification loop and the boundary of this module: factor XI is activated by factor XIIa of the contact system, by thrombin, and by factor XIa itself. Unusually for the cascade it is a disulfide-linked dimer and is not vitamin K-dependent.

PMID:1652157
Thrombin, not only factor XIIa, activates factor XI, and factor XIa autoactivation contributes.
A revised model of coagulation is proposed in which factor XI is activated by thrombin. In the absence of cofactors, thrombin is more effective (kcat/Km = 1.6 x 10(5)) than factor XIIa (1.7 x 10(4)) in activating factor XI.
Factor IXa proteolytic activation of factor X
f9_intrinsic_tenase
Participant: Gene Product: F9
Gene Product:

Function

serine-type endopeptidase activityGO:0004252
Substrates: coagulation factor XUniProtKB:P00742
Cofactors: coagulation factor VIIIaUniProtKB:P00451

Processes

blood coagulation, intrinsic pathwayGO:0007597

Locations

plasma membraneGO:0005886

Catalytic subunit of the intrinsic tenase. Activated by two sequential cleavages (by factor XIa or by the extrinsic tenase); its calcium- and phospholipid-binding Gla and EGF domains hold it on the membrane.

PMID:6782101
Factor IXa activates factor X, and the reaction was characterised with and without its cofactor factor VIIIa and phospholipid.
The kinetic parameters of bovine factor X activation by bovine factor IXa have been determined in the absence and presence of Ca2+, thrombin-activated bovine factor VIII (VIIIa), and phospholipid
Factor VIIIa cofactor activity in the intrinsic tenase
f8_tenase_cofactor
Participant: Gene Product: F8
Gene Product:

Function

endopeptidase activator activityGO:0061133
Targets: coagulation factor IXaUniProtKB:P00740

Processes

blood coagulation, intrinsic pathwayGO:0007597

Locations

plasma membraneGO:0005886

Non-enzymatic cofactor; thrombin cleavage converts the procofactor factor VIII into factor VIIIa, which assembles with factor IXa and raises factor X activation to physiologically useful rates. Its loss causes haemophilia A.

PMID:3082357
Thrombin proteolysis generates the factor VIIIa fragments and this correlates with maximum coagulant activity.
Maximum coagulant activity of thrombin-activated factor VIII was correlated with the generation of these polypeptides.
PMID:6782101
Factor VIIIa is the cofactor whose presence defines the intrinsic tenase reaction studied here.
thrombin-activated bovine factor VIII (VIIIa)
von Willebrand factor carriage of factor VIII
vwf_fviii_carrier
Participant: Gene Product: VWF
Gene Product:

Function

protein carrier chaperoneGO:0140597
Cargo: coagulation factor VIIIUniProtKB:P00451

Locations

extracellular regionGO:0005576

Included only in its factor VIII carrier role, which is the edge the RGD diagram draws (F8 associated with Vwf): VWF binds factor VIII through its D'D3 region, keeps it in circulation and delivers it to the injury site, and thrombin then releases factor VIIIa. VWF's platelet-adhesion functions belong to primary haemostasis, outside this module; see its gene review.

PMID:9759493
VWF is the carrier of factor VIII and this interaction is needed for normal factor VIII survival in plasma.
VWF also is a carrier protein for blood clotting factor VIII, and this interaction is required for normal factor VIII survival in the circulation.
Part 3: thrombin feedback activation of cofactors and factor XI
Thrombin feedback activation of factor V, factor VIII and factor XIRegulatory Stepcoag_thrombin_feedback

The trace thrombin made during initiation cleaves the procofactors factor V and factor VIII to factor Va and factor VIIIa and activates factor XI, converting a slow initiation into explosive propagation. The lag phase of thrombin generation is essentially the time taken by this step.

Annotons

Thrombin activation of factor V, factor VIII and factor XI
f2_cofactor_feedback
Participant: Gene Product: F2
Gene Product:

Function

serine-type endopeptidase activityGO:0004252
Substrates: coagulation factor VUniProtKB:P12259 coagulation factor VIIIUniProtKB:P00451 coagulation factor XIUniProtKB:P03951

Processes

positive regulation of blood coagulationGO:0030194

Locations

extracellular regionGO:0005576

The amplifying feedback arm of thrombin, distinct from its fibrinogen-cleaving and protein C-activating activities modelled in parts 5, 6 and 7. Factor V is activated by both thrombin and factor Xa.

PMID:8083241
In a reconstituted tissue-factor pathway the lag before propagation is the interval of factor V and factor VIII activation, and factor V is activated by both factor Xa and thrombin.
Analyses of the activation pattern of factor V indicated that the cofactor is activated by both factor Xa and thrombin which are formed at low levels during the lag phase of the reaction.
PMID:8083241
Without factor V no thrombin is formed; the cofactors are obligatory.
When factor V was deleted from the reaction mixture, no thrombin formation was observed.
PMID:1652157
Thrombin activates factor XI more efficiently than factor XIIa does.
In the absence of cofactors, thrombin is more effective (kcat/Km = 1.6 x 10(5)) than factor XIIa (1.7 x 10(4)) in activating factor XI.
PMID:3082357
Thrombin cleavage activates factor VIII.
Maximum coagulant activity of thrombin-activated factor VIII was correlated with the generation of these polypeptides.
Part 4: common pathway — prothrombin activation
Prothrombinase (factor Xa-factor Va) activation of prothrombinReactioncoag_prothrombinase

Factor Xa, with factor Va, calcium and a procoagulant phospholipid surface, forms the prothrombinase complex and cleaves prothrombin to thrombin. The assembled complex is some three orders of magnitude faster than factor Xa alone and shifts the reaction pathway so that thrombin, rather than the prethrombin 2 intermediate, is the product.

blood coagulation, common pathwayGO:0072377

Annotons

Factor Xa proteolytic activation of prothrombin
f10_prothrombinase
Participant: Gene Product: F10
Gene Product:

Function

serine-type endopeptidase activityGO:0004252
Substrates: prothrombinUniProtKB:P00734
Cofactors: coagulation factor VaUniProtKB:P12259

Processes

blood coagulation, common pathwayGO:0072377

Locations

plasma membraneGO:0005886

Convergence point of the extrinsic and intrinsic routes; the catalytic subunit of prothrombinase, held on the anionic phospholipid surface by its Gla domain (F10 also carries phospholipid binding, GO:0005543, IDA).

PMID:7350159
The complete prothrombinase complex activates prothrombin with a Vmax about three orders of magnitude above factor Xa alone.
For the complete prothrombinase complex (Xa, Va, Ca2+, and 7.5 microM phospholipid), a Km for prothrombin of 0.21 microM and a Vmax of 1919 mol min-1 mol of Xa-1 is found.
Factor Va cofactor activity in prothrombinase
f5_prothrombinase_cofactor
Participant: Gene Product: F5
Gene Product:

Function

endopeptidase activator activityGO:0061133
Targets: coagulation factor XaUniProtKB:P00742

Processes

blood coagulation, common pathwayGO:0072377

Locations

plasma membraneGO:0005886

Non-enzymatic cofactor activated by thrombin and factor Xa; it both accelerates prothrombin cleavage and redirects it to give thrombin rather than prethrombin 2 as the main product. It is the target of activated protein C.

PMID:7350159
Factor Va changes the product distribution of prothrombin activation to thrombin.
In the presence of factor Va, thrombin is the main end product and minute amounts of prethrombin 2 are formed.
Part 5: fibrin formation
Thrombin cleavage of fibrinogen and fibrin polymerisationReactioncoag_fibrin_formation

Thrombin removes fibrinopeptides A and B from the fibrinogen Aalpha and Bbeta chains; the resulting fibrin monomers self-assemble into double-stranded fibrils that associate laterally and branch into the clot network.

Annotons

Thrombin cleavage of fibrinogen
f2_fibrinogen_cleavage
Participant: Gene Product: F2
Gene Product:

Function

serine-type endopeptidase activityGO:0004252
Substrates: fibrinogen alpha chainUniProtKB:P02671 fibrinogen beta chainUniProtKB:P02675

Processes

blood coagulation, fibrin clot formationGO:0072378

Locations

extracellular regionGO:0005576

The terminal protease of the cascade in its clot-forming role. Cleavage of fibrinopeptide A initiates polymerisation; the slower release of fibrinopeptide B exposes a second polymerisation site.

PMID:16102057
Thrombin cleavage of fibrinopeptide A from the Aalpha chains initiates fibrin polymerisation.
Fibrin is formed after thrombin cleavage of fibrinopeptide A (FPA) from fibrinogen Aalpha-chains, thus initiating fibrin polymerization.
Fibrinogen alpha chain in fibrin network assembly
fga_fibrin_polymer
Participant: Gene Product: FGA
Gene Product:

Function

structural molecule activityGO:0005198

Processes

blood coagulation, fibrin clot formationGO:0072378 protein polymerizationGO:0051258

Locations

extracellular regionGO:0005576

Carries fibrinopeptide A, whose removal starts polymerisation, and contributes the alphaC regions to the clot. Fibrinogen is thrombin's substrate, but building the network is fibrinogen's own work, so its role here is structural, not proteolytic.

PMID:16102057
Fibrils assemble by the fibrin molecules' own end-to-middle and lateral associations to create the clot network.
Double-stranded fibrils form through end-to-middle domain (D:E) associations, and concomitant lateral fibril associations and branching create a clot network.
Fibrinogen beta chain in fibrin network assembly
fgb_fibrin_polymer
Participant: Gene Product: FGB
Gene Product:

Function

structural molecule activityGO:0005198

Processes

blood coagulation, fibrin clot formationGO:0072378 protein polymerizationGO:0051258

Locations

extracellular regionGO:0005576

Carries fibrinopeptide B, released more slowly than FPA, and the beta15-42 sequence exposed by cleavage.

PMID:16102057
Each fibrinogen molecule is built from disulfide-bridged Aalpha, Bbeta and gamma chains, so all three genes contribute to the polymer.
Fibrinogen molecules are comprised of two sets of disulfide-bridged Aalpha-, Bbeta-, and gamma-chains.
Fibrinogen gamma chain in fibrin network assembly and cross-linking
fgg_fibrin_polymer
Participant: Gene Product: FGG
Gene Product:

Function

structural molecule activityGO:0005198

Processes

blood coagulation, fibrin clot formationGO:0072378 protein polymerizationGO:0051258

Locations

extracellular regionGO:0005576

Supplies the glutamine and lysine partners that factor XIIIa joins: assembly aligns gamma-chain pairs antiparallel, and cross-linking them gives the gamma-dimers of a stabilised clot. This is the one place where a substrate of the cross-linking reaction also positions the residues it donates.

PMID:16102057
Fibrin assembly aligns gamma-chain pairs that factor XIII or XIIIa then cross-links into gamma-dimers.
Fibrin assembly facilitates intermolecular antiparallel C-terminal alignment of gamma-chain pairs, which are then covalently 'cross-linked' by factor XIII ('plasma protransglutaminase') or XIIIa to form 'gamma-dimers'.
Part 6: clot stabilisation by cross-linking
Factor XIII activation and cross-linking of fibrinReactioncoag_fibrin_crosslinking

Thrombin activates plasma factor XIII, a tetramer of two catalytic A subunits and two carrier B subunits; factor XIIIa then forms epsilon-(gamma-glutamyl)lysine bonds between fibrin chains, stabilising the clot and protecting it from lysis.

Annotons

Thrombin activation of plasma factor XIII
f2_f13_activation
Participant: Gene Product: F2
Gene Product:

Function

serine-type endopeptidase activityGO:0004252
Substrates: coagulation factor XIII A chainUniProtKB:P00488

Processes

blood coagulation, fibrin clot formationGO:0072378

Locations

extracellular regionGO:0005576

Thrombin cleavage of the A subunit activation peptide is the main route to factor XIIIa; factor XIII is activated in the last stage of coagulation, on the fibrin it will cross-link.

PMID:21742792
Factor XIII is a protransglutaminase activated at the end of the cascade, acting on an insoluble substrate.
it is a protransglutaminase, which becomes activated in the last stage of coagulation
Factor XIIIa cross-linking of fibrin
f13a1_transglutaminase
Participant: Gene Product: F13A1
Gene Product:

Function

protein-glutamine gamma-glutamyltransferase activityGO:0003810
Substrates: fibrin gamma chainUniProtKB:P02679 fibrin alpha chainUniProtKB:P02671

Processes

peptide cross-linkingGO:0018149 blood coagulation, fibrin clot formationGO:0072378

Locations

extracellular regionGO:0005576

The only transferase in the cascade: a calcium-dependent transglutaminase that ligates gamma-chain pairs and then alpha chains, determining clot viscoelasticity and resistance to fibrinolysis.

PMID:21742792
Factor XIIIa stabilises the fibrin clot and protects fibrin against fibrinolysis.
stabilization of fibrin clot, and protection of fibrin against fibrinolysis
PMID:16102057
Factor XIII or XIIIa cross-links aligned gamma-chain pairs into gamma-dimers.
which are then covalently 'cross-linked' by factor XIII ('plasma protransglutaminase') or XIIIa to form 'gamma-dimers'
Factor XIII B subunit carriage of the catalytic A subunit
f13b_carrier
Participant: Gene Product: F13B
Gene Product:

Processes

blood coagulation, fibrin clot formationGO:0072378

Locations

extracellular regionGO:0005576

Non-catalytic subunit of the plasma A2B2 tetramer; it carries the A subunit in plasma, keeps it from being activated prematurely, and dissociates on activation. No molecular function is asserted: GOA gives F13B only the fibrin-clot-formation process (IDA), and GO has no term for this carrier role.

PMID:16102057
The plasma factor XIII A2B2 complex is the form bound by fibrinogen, which suppresses its cross-linking activity in blood.
suppression of plasma factor XIII-mediated cross-linking activity in blood by binding the factor XIII A2B2 complex
Part 7: anticoagulant regulation
Plasma anticoagulant systems restraining the cascadeRegulatory Stepcoag_anticoagulant_regulation

Four systems keep the cascade local and self-limiting: antithrombin traps thrombin, factor Xa and factor IXa; tissue factor pathway inhibitor blocks the extrinsic tenase and factor Xa; thrombin bound to endothelial thrombomodulin activates protein C, which with protein S destroys factors Va and VIIIa; and protein Z-dependent protease inhibitor with protein Z inactivates factor Xa at the membrane.

negative regulation of blood coagulationGO:0030195

Annotons

Antithrombin inhibition of thrombin, factor Xa and factor IXa
serpinc1_antithrombin
Participant: Gene Product: SERPINC1
Gene Product:

Function

serine-type endopeptidase inhibitor activityGO:0004867
Targets: thrombinUniProtKB:P00734 coagulation factor XaUniProtKB:P00742 coagulation factor IXaUniProtKB:P00740

Processes

negative regulation of blood coagulationGO:0030195

Locations

extracellular regionGO:0005576

Suicide-substrate serpin and the broadest brake in the system, hitting three of the module's proteases. Heparin or endothelial heparan sulfate accelerates it, allosterically for factor Xa and by bridging for thrombin — the basis of heparin therapy.

PMID:10497166
Heparin activates antithrombin against factor Xa allosterically and against thrombin by a bridging mechanism.
A sequence-specific heparin pentasaccharide activates the serpin, antithrombin, to inhibit factor Xa through an allosteric mechanism, whereas full-length heparin chains containing this sequence further activate the serpin to inhibit thrombin by an alternative bridging mechanism.
Tissue factor pathway inhibitor shutdown of the extrinsic tenase
tfpi_extrinsic_brake
Participant: Gene Product: TFPI
Gene Product:

Function

serine-type endopeptidase inhibitor activityGO:0004867
Targets: coagulation factor VIIa in the tissue factor complexUniProtKB:P08709 coagulation factor XaUniProtKB:P00742

Processes

negative regulation of blood coagulationGO:0030195

Locations

plasma membraneGO:0005886

Kunitz-type inhibitor that needs catalytically active factor Xa to quench the factor VIIa-tissue factor complex, and inhibits factor Xa in its own right; this is why extrinsic initiation is self-limiting and amplification is required. GOA gives the parent endopeptidase inhibitor activity (GO:0004866, TAS) and the serine-type child by IBA; both targets are serine proteases, so the child is used here.

PMID:3422166
Inhibition of tissue factor activity requires factor VIIa, active factor Xa, calcium and the inhibitor, which also inhibits factor Xa directly.
This process is reversible and requires the presence of VII(a), catalytically active Xa, Ca2+, and another component that appears to be associated with the lipoproteins in plasma, a lipoprotein-associated coagulation inhibitor (LACI).
PMID:3422166
The same inhibitor inhibits factor Xa.
LACI(HG2) also inhibited Xa with an apparent t1/2 of 50 seconds.
Thrombomodulin redirection of thrombin to protein C activation
thbd_thrombin_switch
Participant: Gene Product: THBD
Gene Product:

Function

signaling receptor activityGO:0038023

Processes

negative regulation of blood coagulationGO:0030195

Locations

plasma membraneGO:0005886

Endothelial membrane cofactor that binds thrombin and converts it from a procoagulant protease into an activator of protein C, raising the rate of protein C activation by orders of magnitude. This is a cofactor role like those of F3, F5 and F8, which this module gives endopeptidase activator activity. GO:0038023 signaling receptor activity is kept here only because thrombomodulin's IDA annotation and all four cached protein C GO-CAMs use it; it does not describe a signal-transducing step.

PMID:7017729
The endothelial surface supplies a cofactor that greatly enhances thrombin-catalysed protein C activation.
It is proposed that the surface of vascular endothelium provides a cofactor that enhances the rate of protein C activation by thrombin.
PMID:7017729
Endothelial monolayers accelerate thrombin-catalysed protein C activation.
Cultured monolayers of human endothelium enhance the rate of thrombin-catalyzed protein C activation.
Thrombin activation of protein C
f2_protein_c_activation
Participant: Gene Product: F2
Gene Product:

Function

serine-type endopeptidase activityGO:0004252
Substrates: protein CUniProtKB:P04070
Cofactors: thrombomodulinUniProtKB:P07204

Processes

negative regulation of blood coagulationGO:0030195

Locations

extracellular regionGO:0005576

Thrombin's anticoagulant face: bound to thrombomodulin it cleaves protein C, turning the cascade's end product into the trigger of its own shutdown.

PMID:7017729
Protein C is activated by thrombin, and dramatically faster in the presence of the endothelial cofactor.
The rate of activated protein C formation during the transit through the myocardium is at least 20,000 times that of thrombin-catalyzed activation of protein C in the perfusion solution.
Activated protein C inactivation of factors Va and VIIIa
proc_cofactor_inactivation
Participant: Gene Product: PROC
Gene Product:

Function

serine-type endopeptidase activityGO:0004252
Substrates: coagulation factor VaUniProtKB:P12259 coagulation factor VIIIaUniProtKB:P00451
Cofactors: protein SUniProtKB:P07225

Processes

negative regulation of blood coagulationGO:0030195

Locations

extracellular regionGO:0005576

Vitamin K-dependent protease that removes the two cofactors the cascade cannot work without, cleaving factor Va at Arg306 and Arg506 and factor VIIIa in its heavy chain. Its loss or resistance of factor V to its cleavage causes thrombophilia.

PMID:9065469
In a reconstituted tissue-factor pathway the protein C arm shuts down thrombin generation by inactivating factor Va.
Our data thus suggest that the protein C pathway regulates thrombin generation solely by the inactivation of factor Va.
PMID:3082357
Activated protein C cleaves factor VIII, and this cleavage correlates with loss of its coagulant activity.
This cleavage correlated with inactivation of factor VIII by APC.
Protein S cofactor activity for activated protein C
pros1_apc_cofactor
Participant: Gene Product: PROS1
Gene Product:

Function

peptidase activator activityGO:0016504
Targets: activated protein CUniProtKB:P04070

Processes

negative regulation of blood coagulationGO:0030195

Locations

extracellular regionGO:0005576

Vitamin K-dependent, non-enzymatic cofactor that accelerates APC-catalysed inactivation of factor Va on a phospholipid surface, and also assists TFPI. Not on the RGD curated gene list but drawn in the textbook protein C pathway (RGD's own PW:0000480) and named in the PW:0000474 description as the protein S component of that pathway.

PMID:6892911
Protein S greatly enhances the rate at which activated protein C inactivates factor Va, and has no effect on factor Va by itself.
Purified cofactor-protein S caused a large enhancement in the rate of inactivation of Factor Va by activated protein C in the presence of phospholipid.
Protein Z-dependent protease inhibitor inactivation of factor Xa
serpina10_zpi
Participant: Gene Product: SERPINA10
Gene Product:

Function

serine-type endopeptidase inhibitor activityGO:0004867
Targets: coagulation factor XaUniProtKB:P00742

Processes

negative regulation of blood coagulationGO:0030195

Locations

plasma membraneGO:0005886

Serpin whose inhibition of factor Xa is fast only when protein Z, calcium and a phospholipid surface are present, forming a ternary factor Xa-PZ-ZPI complex at the membrane.

PMID:9689066
ZPI inhibition of factor Xa is rapid and strictly requires protein Z, calcium and phospholipid.
the factor Xa inhibition produced by ZPI is rapid (>95% within 1 min by coagulation assay) and requires the presence of PZ, calcium ions, and cephalin.
Protein Z cofactor in the factor Xa-PZ-ZPI complex
proz_membrane_cofactor
Participant: Gene Product: PROZ
Gene Product:

Processes

negative regulation of blood coagulationGO:0030195

Locations

plasma membraneGO:0005886

Vitamin K-dependent protein with a protease-like but catalytically degenerate domain; it tethers ZPI and factor Xa to the phospholipid surface. No molecular function is asserted: GOA offers only protein binding and an IBA serine-type endopeptidase activity that is implausible for a pseudoprotease, and GO has no term for this membrane-cofactor role.

PMID:9689066
The inhibitory reaction proceeds through a factor Xa-protein Z-ZPI complex at the phospholipid surface.
The inhibitory process appears to involve the formation of a factor Xa-PZ-ZPI complex at the phospholipid surface.